Company news

Scribe Therapeutics Inc. news

Latest news releases, newest first.

View company

Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences

November 5, 2026

Scribe Therapeutics to Present Updated Data on PCSK9-Targeting Epigenetic Silencing and LPA-Targeting Gene Editing Programs at American Heart Association (AHA) Scientific Sessions 2026

November 4, 2026

Decks